Dynorphin stimulates corticotropin release from mouse anterior pituitary AtT-20 cells through nonopioid mechanisms

Neuroendocrinology

Volumn 71, Issue 3, 2000, Pages 170-176

  Cheng, Peter Y ^a   Birk, Alex V ^a   Gershengorn, Marvin C ^a   Szeto, Hazel H ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Analgesics; Corticotropin; Corticotropin releasing hormone; Dynorphin; Excitatory amino acids; Opioid peptides; Opioid receptors; Stress

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; CORTICOTROPIN; DECAHYDRO 6 PHOSPHONOMETHYL 3 ISOQUINOLINECARBOXYLIC ACID; DYNORPHIN A; KAPPA OPIATE RECEPTOR AGONIST; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NALOXONE; OPIATE; OPIATE RECEPTOR; PEPTIDE FRAGMENT;

ADENOHYPOPHYSIS; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CORTICOTROPIN RELEASE; DOSE RESPONSE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0034015101     PISSN: 00283835     EISSN: None     Source Type: Journal    
DOI: 10.1159/000054534     Document Type: Article

References (37)

1. Fischli W, Goldstein A, Hunkapiller MW, Hood LE: Isolation and amino acid sequence analysis of a 4,000-dalton dynorphin from porcine pituitary. Proc Natl Acad Sci USA 1982; 79:5435-5437.
2. 1-13 stimulates ovine fetal pituitary-adrenal function through a novel non-opioid mechanism. J Pharmacol Exp Ther 1997;280:416-421.
3. Taylor CC, Wu DL, Soong Y, Yee J. Szeto HH: Differential mechanisms of ovine fetal pituitary stimulation by a selective kappa-opioid agonist and by dynorphin. Neuroendocrinology 1996;64:419-424.
4. Shukla VK, Lemaire S: Non-opioid effects of dynorphins: Possible role of the NMDA receptor. Trends Pharmacol Sci 1994;15:420-424.
5. 1-13. Neuroendocrinology 1999;69:28-33.
6. Antoni FA: Hypothalamic control of adrenocorticotropin secretion: Advances since the discovery of 41-residue corticotropin-releasing factor. Endocr Rev 1986;7:351-378.
7. Abou-Samra AB, Catt KJ, Aguilera G: Role of arachidonic acid in regulation of adrenocorticotropin release from rat anterior pituitary cell cultures. Endocrinology 1986;119:1427-1431.
8. Roth KA, Weber E, Barchas JD, Chang D, Chang JK: Immunoreactive dynorphin-(1-8) and corticotropin-releasing factor in subpopulation of hypothalamic neurons. Science 1982; 216:85-87.
9. Watson SJ, Akil H, Fischli W, Goldstein A, Zimmerman E, Nilaver G, van Wimersma Greidanus TB: Dynorphin and vasopressin: Common localization in magnocellular neurons. Science 1982;216:85-87.
10. Adamson WT, Windh RT, Blackford S, Kuhn CM: Ontogeny of mu-and kappa-opiate receptor control of the hypothalamo-pituitary-adrenal axis in rats. Endocrinology 1991;129:959-964.
11. Iyengar S, Kim SH, Wood PL: Mu-, delta-, kappa-and epsilon-opioid receptor modulation of the hypothalamic-pituitary-adrenocorticoal (HPA) axis: Subchronic tolerance studies of endogenous opioid peptides. Brain Res 1987; 435:220-226.
12. Milanes MV, Gonzalvez ML, Fuente T. Vargas ML: Pituitary-adrenocortical response to acute and chronic administration of U50,488H in the rat. Neuropeptides 1991;20:95-102.
13. Skilling SR, Sun X, Kurtz HJ, Larson AA: Selective potentiation of NMDA-induced activity and release of excitatory amino acids by dynorphin: Possible role in paralysis and neurotoxicity. Brain Res 1992;575:272-278.
14. Caudle RM, Isaac L: A novel interaction between dynorphin(1-13) and an N-methyl-D-aspartate site. Brain Res 1988;443:329-332.
15. Bakshi R, Faden AI: Blockade of the glycine modulatory site of NMDA receptors modifies dynorphin-induced behavioral effects. Neurosci Lett 1990;110:113-117.
16. Bakshi R, Faden AI: Competitive and noncompetitive NMDA antagonists limit dynorphin A-induced rat hindlimb paralysis. Brain Res 1990;507:1-5.
17. Isaac L, Van Zandt OT, Ristic H, Stewart P: MK-801 blocks dynorphin A(1-13)-induced loss of the tail-flick reflex in the rat. Brain Res 1990;531:83-87.
18. Caudle RM, Chavkin C, Dubner R: Kappa-2-opioid receptors inhibit NMDA receptor-mediated synaptic currents in guinea pig CA3 pyramidal cells. J Neurosci 1994;14:5580-5589.
19. Shukla VK, Bansinath M, Dumont M, Lemaire S: Selective involvement of kappa-opioid and phencyclidine receptors in the analgesic and motor effects of dynorphin-A-(1-13)-Tyr-Leu-Phe-Asn-Gly-Pro. Brain Res 1992;591:176-180.
20. 3H]CGP-39653 binding to rat brain membranes. Eur J Pharmacol 1994;271:241-244.
21. Brann DW: Glutamate: A major excitatory transmitter in neuroendocrine regulation. Neuroendocrinology 1995;61:213-225.
22. Terry LC, Epelbaum J, Martin JB: Monosodium glutamate: Acute and chronic effects on rhythmic growth hormone and prolactin secretion, and somatostatin in the undisturbed male rat. Brain Res 1981;217:129-142.
23. Mason GA, Bissette G, Nemeroff CB: Effects of excitotoxic amino acids on pituitary hormone secretion in the rat. Brain Res 1983;289: 366-369.
24. Bardgett ME, Taylor GT, Farah JM Jr: Systemic NMDA treatment increases plasma ACTH in the neonatal female and male rat. Brain Res Dev Brain Res 1992;68:289-293.
25. Jezova D, Oliver C, Jurcovicova J: Stimulation of adrenocorticotropin but not prolactin and catecholamine release by N-methyl-aspartic acid. Neuroendocrinology 1991;54:488-492.
26. Brooks AN, Howe DC: Adrenocorticotrophin and luteinizing hormone responses to N-methyl-D-aspartate during fetal development in sheep. J Neuroendocrinol 1996;8:315-321.
27. Bhat GK, Mahesh VB, Chu ZW, Chorich LP, Zamorano PL, Brann DW: Localization of the N-methyl-D-aspartate R1 receptor subunit in specific anterior pituitary hormone cell types of the female rat. Neuroendocrinology 1995;62: 178-186.
28. Mahesh VB, Zamorano P, De Sevilla L, Lewis D, Brann DW: Characterization of ionotropic glutamate receptors in rat hypothalamus, pituitary and immortalized gonadotropin-releasing hormone (GnRH) neurons (GT1-7 cells). Neuroendocrinology 1999;69:397-407.
29. Villalobos C, Nunez L, Garcia-Sancho J: Functional glutamate receptors in a subpopulation of anterior pituitary cells. FASEB J 1996;10: 654-660.
30. Login IS: Direct stimulation of pituitary prolactin release by glutamate. Life Sci 1990;47: 2269-2275.
31. Lindstrom P, Ohlsson L: Effect of N-methyl-D.I.-aspartate on isolated rat somatotrophs. Endocrinology 1992;131:1903-1907.
32. Lutz-Bucher B, Jeandel L, Heisler S, Roberts JL, Koch B: Evidence that AVP receptors in AtT-20 corticotrophs are not coupled to secretion of POMC-derived peptides. Mol Cell Endocrinol 1987;53:161-167.
33. Zanisi M, Galbiati M, Messi E, Martini L: The anterior pituitary gland as a possible site of action of kainic acid. Proc Soc Exp Biol Med 1994;206:431-437.
34. Calogero AE, Scaccianoce S, Burrello N, Nicolai R, Muscolo LAA, Kling MA, Angelucci L, D'Agata R: The kappa-opioid receptor agonist MR-2034 stimulates the rat hypothalamic-pituitary-adrenal axis: Studies in vivo and in vitro. J Neuroendocrinol 1996;8:579-585.
35. Yarygin KN, Zhang XH, Lee NM: Non-opioid dynorphin binding site on secretory vesicles of a pituitary-derived cell line. Brain Res 1998; 791:99-107.
36. Pechnick RN: Effects of opioids on the hypothalamo-pituitary-adrenal axis. Annu Rev Pharmacol Toxicol 1993;33:353-382.
37. Gambus PL, Schnider TW, Minto CF, Youngs EJ, Billard V, Brose WG, Hochhaus G, Shafer SL: Pharmacokinetics of intravenous dynorphin A(1-13) in opioid-naive and opioid-treated human volunteers. Clin Pharmacol Ther 1998;64:27-38.